← All stocks

Orchestra BioMed Holdings, Inc.

OBIO Net buying

CIK 0001814114 #3499 in the set updated 17 Sep 2026

Bought (1 mo)

$58.56K

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$74.10K

$74.10K on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$15.54K

+$58.56K against sales at will

By person

12 insiders · 3 transactions

15.6×

David P. Hochman holds 15.6 times base salary in stock. $9.32M of shares against $595.00K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Hochman last reported holding, valued at $4.79, the price Common Stock, par value $0.0001 per share ("Common Stock") was last bought or sold at on the open market here, on 3 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sherman Darren

See Remarks

$10.66K (1)

$74.10K (1) scheduled

−$63.44K

1,136,402

1.89%

$5.44M

+48.4%

Hochman David P

See Remarks

$47.90K (1)

—

+$47.90K

1,945,718

3.24%

$9.32M

+47.1%

RTW INVESTMENTS, LP entity

10% owner

—

9,556,063

15.90%

$45.77M

+16.4%

PERCEPTIVE ADVISORS LLC entity

10% owner

—

5,292,556

8.81%

$25.35M

+15.2%

Taylor Andrew Lawrence

Chief Financial Officer

—

589,989

0.9816%

$2.83M

+55.9%

Aryeh Jason

Director

—

118,118

0.1965%

$565.79K

+72.8%

Fain Eric S

Director

—

107,130

0.1782%

$513.15K

+119.9%

Mack John Prosper

Director

—

66,544

0.1107%

$318.75K

+417.3%

Connealy Pamela Ann

Director

—

66,038

0.1099%

$316.32K

+210.2%

Pacitti David

Director

—

54,750

0.0911%

$262.25K

+212.0%

Cleary Chris

Director

—

29,153

0.0485%

$139.64K

—

Aiello Joshua

Principal Accounting Officer

—

18,441

0.0307%

$88.33K

+268.8%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Hochman David P

3 Sep 2026

See Remarks

Buy

10,000

$4.79

$47.90K

Sherman Darren

26 Aug 2026

See Remarks

Buy indirect

2,000

$5.33

$10.66K

Show all 3 transactions →

What was left out

Form 4 filings counted 6

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 14,770

History held since 6 Aug 2020